BSX vs DOCS
Boston Scientific Corp (BSX) versus Doximity Inc (DOCS) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
Doximity Inc (DOCS) is a health information services company listed on US.
Latest reported BSX revenue for 2024-12-31 was $16.75B. Net income was $1.85B. Revenue was up 17.6% from 2023-12-31 to 2024-12-31. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Latest reported DOCS revenue for 2025-03-31 was $570.4M. Net income was $223.2M. Revenue was up 20.0% from 2024-03-31 to 2025-03-31. DOCS currently screens at market cap $3.77B and trailing P/E 21.0.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. DOCS currently screens at market cap $3.77B and trailing P/E 21.0.
Not investment advice. Open the BSX and DOCS stock pages for the full models.
Not investment advice.